109 related articles for article (PubMed ID: 21665542)
1. Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation.
Nardo LG; Fleming R; Howles CM; Bosch E; Hamamah S; Ubaldi FM; Hugues JN; Balen AH; Nelson SM
Reprod Biomed Online; 2011 Aug; 23(2):141-8. PubMed ID: 21665542
[TBL] [Abstract][Full Text] [Related]
2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
[TBL] [Abstract][Full Text] [Related]
4. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
[TBL] [Abstract][Full Text] [Related]
5. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2).
Eijkemans MJ; Polinder S; Mulders AG; Laven JS; Habbema JD; Fauser BC
Hum Reprod; 2005 Oct; 20(10):2830-7. PubMed ID: 16006473
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
[TBL] [Abstract][Full Text] [Related]
7. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction.
Al-Azemi M; Killick SR; Duffy S; Pye C; Refaat B; Hill N; Ledger W
Hum Reprod; 2011 Feb; 26(2):414-22. PubMed ID: 21147822
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of ovarian response: current and future applications.
Nelson SM
Fertil Steril; 2013 Mar; 99(4):963-9. PubMed ID: 23312225
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
10. [New developments in ovarian stimulation].
Griesinger G; Diedrich K
Gynakol Geburtshilfliche Rundsch; 2009; 49(2):55-61. PubMed ID: 19346749
[TBL] [Abstract][Full Text] [Related]
11. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
12. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.
Lekamge DN; Lane M; Gilchrist RB; Tremellen KP
J Assist Reprod Genet; 2008; 25(11-12):515-21. PubMed ID: 18972201
[TBL] [Abstract][Full Text] [Related]
13. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
Iwase A; Ando H; Kuno K; Mizutani S
Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
15. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
[TBL] [Abstract][Full Text] [Related]
17. Mild ovarian stimulation for IVF.
Verberg MF; Macklon NS; Nargund G; Frydman R; Devroey P; Broekmans FJ; Fauser BC
Hum Reprod Update; 2009; 15(1):13-29. PubMed ID: 19091755
[TBL] [Abstract][Full Text] [Related]
18. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
19. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
Yu M; Deng CY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis.
Sterrenburg MD; Veltman-Verhulst SM; Eijkemans MJ; Hughes EG; Macklon NS; Broekmans FJ; Fauser BC
Hum Reprod Update; 2011; 17(2):184-96. PubMed ID: 20843965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
